Time to first morning cigarette and risk of chronic obstructive pulmonary disease: Smokers in the PLCO Cancer Screening Trial

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Guertin, Kristin A ^a   Gu, Fangyi ^b   Wacholder, Sholom ^c   Freedman, Neal D ^a   Panagiotou, Orestis A ^c   Reyes Guzman, Carolyn ^b   Caporaso, Neil E ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Genetic Epidemiology Branch Division of Cancer Epidemiology and Genetics Department of Health and Human Services ^*  (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; AGE; AGED; ARTICLE; CAUCASIAN; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EMPHYSEMA; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PREVALENCE; RACE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING HABIT; TIME TO FIRST MORNING CIGARETTE; TOBACCO DEPENDENCE; CASE CONTROL STUDY; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TOBACCO USE DISORDER;

AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TOBACCO USE DISORDER;

EID: 84930622691     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125973     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses - United States, 2000-2004. MMWR: Morbidity and Mortality Weekly Report. 2008; 57:1226-8. Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5745a3.htm. PMID: 19008791
2. National Heart Lung and Blood Institute. Morbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases. 2012. Available from: Available: http://www.nhlbi.nih.gov/files/docs/research/2012-ChartBook-508.pdf.
3. van der Meer RM, Wagena EJ, Ostelo RW, Jacobs JE, van Schayck CP. Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2001 (1:). doi: 10.1002/14651858
4. Kanner RE, Connett JE, Williams DE, Buist AS. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med. 1999 Apr; 106(4):410-6. PMID: 10225243. doi: 10.1016/S0002-9343(99)00056-X
5. Anthonisen NR, Connett JE, Murray RP. Smoking and Lung Function of Lung Health Study Participants after 11 Years. American Journal of Respiratory and Critical Care Medicine. 2002 September 1; 166 (5):675-9. doi: 10.1164/rccm.2112096 PMID: 12204864
6. Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults - United States, 2005-2012. 2014.
7. Vozoris NT, Stanbrook MB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respiratory Medicine. 2011; 105(3):477-84. doi: 10.1016/j.rmed.2010.08.011 PMID: 20850288
8. Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006; 61(12):1043-7. Pubmed Central PMCID: 2117062. doi: 10.1136/thx.2006.064410 PMID: 17040932
9. Gu F, Wacholder S, Kovalchik S, Panagiotou OA, Reyes-Guzman C, Freedman ND, et al. Time to smoke first morning cigarette and lung cancer in a case - control study. Journal of the National Cancer Institute. 2014; 106(6). doi: 10.1093/jnci/dju118
10. Muscat JE, Ahn K, Richie JP, Stellman SD. Nicotine dependence phenotype and lung cancer risk. Cancer. 2011; 117(23):5370-6. doi: 10.1002/cncr.26236 PMID: 21826644
11. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction. 1991 Sep; 86(9):1119-27. PMID: 1932883.
12. Baker TB, Piper ME, McCarthy DE, Bolt DM, Smith SS, Kim S-Y, et al. Time to First Cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependence. Nicotine & Tobacco Research. 2007 December 1, 2007; 9(Suppl 4):S555-S70. doi: 10.1080/14622200701673480
13. Branstetter SA, Muscat JE. Time to First Cigarette and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) levels in adult smokers: National Health and Nutrition Examination Survey (NHANES) 2007-2010. Cancer Epidemiology Biomarkers & Prevention. 2013 April 1, 2013; 22(4):615-22. doi: 10.1158/1055-9965.epi-12-0842
14. Muscat JE, Stellman SD, Caraballo RS, Richie JP. Time to First Cigarette after waking predicts cotinine levels. Cancer Epidemiology Biomarkers & Prevention. 2009 December 1, 2009; 18(12):3415-20. doi: 10.1158/1055-9965.epi-09-0737
15. Qaseem A, Wilt T, Weinberger S, Hanania N, Criner G, van der Molen T, et al. Diagnosis and management of stable Chronic Obstructive Pulmonary Disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011; 155(3):179-91. doi: 10.7326/0003-4819-155-3-201108020-00008 PMID: 21810710
16. Rostron BL, Chang CM, Pechacek TF. Estimation of cigarette smoking - attributable morbidity in the United States. JAMA Internal Medicine. 2014. doi: 10.1001/jamainternmed.2014.5219
17. Gohagan JK, Prorok PC, Hayes RB, Kramer BS. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status. Control Clin Trials. 2000 Dec; 21(6 Suppl):251S-72S. PMID: 11189683.
18. Prorok P, Andriole G, Bresalier R. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000; 21(6 Suppl):273S-309S. PMID: 11189684
19. Jiménez-Ruiz CA, Masa F, Miravitlles M, Gabriel R, Viejo JL, Villasante C, et al. Smoking characteristics: Differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest. 2001; 119(5):1365-70. doi: 10.1378/chest.119.5.1365 PMID: 11348940
20. Herning RI, Jones RT, Benowitz NL, Mines AH. How a cigarette is smoked determines blood nicotine levels. Clinical pharmacology and therapeutics. 1983 Jan; 33(1):84-90. PMID: 6848303. doi: 10.1038/clpt.1983.12
21. Hecht SS, Carmella SG, Murphy SE, Akerkar S, Brunnemann KD, Hoffmann D. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med. 1993 Nov 18; 329(21):1543-6. PMID: 8413477. doi: 10.1056/NEJM199311183292105
22. Hatsukami DK, Le CT, Zhang Y, Joseph AM, Mooney ME, Carmella SG, et al. Toxicant exposure in cigarette reducers versus light smokers. Cancer Epidemiol Biomarkers Prev. 2006 Dec; 15(12):2355-8. PMID: 17164356. doi: 10.1158/1055-9965.EPI-06-0240
23. Forey BA, Thornton AJ, Lee PN. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulmonary Medicine. 2011; 11:36. PMID: 21672193. Pubmed Central PMCID: 3128042. Epub 2011/06/16. doi: 10.1186/1471-2466-11-36
24. Schnoll RA, Goren A, Annunziata K, Suaya JA. The prevalence, predictors and associated health outcomes of high nicotine dependence using three measures among US smokers. Addiction. 2013; 108 (11):1989-2000. doi: 10.1111/add.12285 PMID: 23795712
25. Kunze U, Schöler E, Schoberberger R, Dittrich C, Aigner K, Bölcskei P, et al. Lung Cancer Risk Measured by the Fagerström Test for Nicotine Dependence? Nicotine & Tobacco Research. 2007 May 1, 2007; 9(5):625-6. doi: 10.1080/14622200601096998
26. Kubik A, Zatloukal P, Tomasek L, Dolezal J, Syllabova L, Kara J, et al. A case-control study of lifestyle and lung cancer associations by histological types. Neoplasma. 2008; 55(3):192-9. PMID: 18348651.
27. Muscat J, Liu H-P, Livelsberger C, Richie J Jr., Stellman S. The nicotine dependence phenotype, time to first cigarette, and larynx cancer risk. Cancer Causes & Control. 2012 2012/03/01; 23(3):497-503. doi: 10.1007/s10552-012-9909-x
28. Jiménez-Ruiz CA, Miravitlles M, Sobradillo V, Gabriel R, Viejo JL, Masa JF, et al. Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease? Nicotine & Tobacco Research. 2004 August 1, 2004; 6 (4):649-53. doi: 10.1080/14622200410001727948
29. Kim DK, Hersh CP, Washko GR, Hokanson JE, Lynch DA, Newell JD, et al. Epidemiology, radiology, and genetics of nicotine dependence in COPD. Respiratory Research. 2011; 12:9. PMID: 21232152. Pubmed Central PMCID: 3033825. doi: 10.1186/1465-9921-12-9
30. Jiménez Ruiz CA, Ramos Pinedo A, Cicero Guerrero A, Mayayo Ulibarri M, Cristobal Fernández M, Lopez Gonzalez G. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications. Nicotine & Tobacco Research. 2012 September 1, 2012; 14(9):1035-9. doi: 10.1093/ntr/nts001
31. Bernstein SL, Boudreaux ED, Cabral L, Cydulka RK, Schwegman D, Larkin GL, et al. Nicotine dependence, motivation to quit, and diagnosis among adult emergency department patients who smoke: A national survey. Nicotine & Tobacco Research. 2008 August 1, 2008; 10(8):1277-82. doi: 10.1080/14622200802239272
32. Berlin I, Singleton EG. Nicotine dependence and urge to smoke predict negative health symptoms in smokers. Preventive Medicine. 2008; 47(4):447-51. doi: 10.1016/j.ypmed.2008.06.008 PMID: 18602945
33. Murgia N, Brisman J, Claesson A, Muzi G, Olin A-C, Toren K. Validity of a questionnaire-based diagnosis of chronic obstructive pulmonary disease in a general population-based study. BMC Pulmonary Medicine. 2014; 14(1):49. doi: 10.1186/1471-2466-14-49